Ranbaxy Innovation and Growth Focus

Key Milestones Ranbaxy has been a trendsetter_for the Indian Pharma Industry 2012 2011 2009 2008 Launched First New Drug from India, Synriam TM, a new age cure for Malaria Arteline Malate and Fiperapute Prophete Tablets Synriam Launched Gx LipitorⓇ, largest pharma product in the world. Crossed $2 Bn in Global Revenue Executive Leadership reconstituted for transition to professionally managed company Hybrid business model with Daiichi Sankyo Daiichi-Sankyo 2004 Crossed $1 Bn in Global Revenue 2001 1998 -Launched its first Para IV product - Cefuroxime Axetil Enters the world's largest Phamra market Crossed Sales of $200 Mn (Rs.1,000 Cr) 1997 with exports over $100 Mn (Rs.500 Cr) 1978 First major step for becoming an MNC. Set up a JV plant in Nigeria 1973 Ranbaxy goes public and was listed subsequently 1961 Ranbaxy incorporated in India $1 = Rs. 50 |RANBAXY Trusted medicines.Healthier lives 7

View entire presentation